$TEVA SEC Filings

Holds 11,943 shares of Ordinary Shares

Received 4,503 shares by exercise or conversion ($156K) · Sold 7,342 shares ($285K)

Sold 367,600 shares ($14.4M)

Creating the series of Securities (as defined herein) designated

On September 14, 2026, Teva Pharmaceutical Industries Ltd. (the “Company”) began trading its ordinary shares on the New York Stock Exchange, in lieu of its American depositary shares (“ADSs”), under the same ticker symbol under which the...

To: the other Euro Underwriters (as defined herein) listed in Part A of Schedule I hereto;

Sold 9,445 shares ($355K) · Received 2,500 shares by exercise or conversion ($49K)

Sold 415 shares ($15.5K)

Sold 18,600 shares ($680K)